Latest News about RGEN
Recent news which mentions RGEN
2 Healthcare Stocks That Could Help Set You Up for Life
January 20, 2022
From Motley Fool
These Are 5 of the Fastest-Growing Large-Cap Stocks on the Planet
January 13, 2022
From Motley Fool
Repligen Corp (RGEN) Q3 2021 Earnings Call Transcript
October 28, 2021
Tickers
RGEN
From Motley Fool
From Benzinga
Earnings Scheduled For October 28, 2021
October 28, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
NIO Stock Is Very Richly Valued, But I Can See Why It Tempts People
October 19, 2021
From InvestorPlace
2 Tricks and a Treat for Gene Therapy Investors
October 18, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
October 14, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
From Benzinga
3 Unstoppable Healthcare Stocks to Buy With Just $1,000
September 22, 2021
From Motley Fool
Great Performers That Are Still Great Stocks
September 21, 2021
From Motley Fool
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
10 Biggest Price Target Changes For Friday
September 17, 2021
From Benzinga
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
From Benzinga
Repligen Reinforces Proteins Business With $150M Avitide Acquisition Deal
September 16, 2021
Tickers
RGEN
From Benzinga
From Benzinga
Chief Executive Officer Of Repligen Trades $8.18 Million In Company Stock
September 14, 2021
Tickers
RGEN
From Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Friday
August 27, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.